These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17636039)

  • 1. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of prostaglandin E
    Mukherjee S; Sengupta Bandyopadhyay S
    Biochem J; 2018 Jan; 475(2):477-494. PubMed ID: 29269396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
    Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
    Bidwell P; Joh K; Leaver HA; Rizzo MT
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line.
    Isobe A; Takeda T; Sakata M; Yamamoto T; Minekawa R; Hayashi M; Auernhammer CJ; Tasaka K; Murata Y
    Placenta; 2006 Aug; 27(8):912-8. PubMed ID: 16300827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
    Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
    Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
    Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
    Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp3 is involved in the regulation of SOCS3 gene expression.
    Ehlting C; Häussinger D; Bode JG
    Biochem J; 2005 May; 387(Pt 3):737-45. PubMed ID: 15554904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.
    Hansen TV; Rehfeld JF; Nielsen FC
    Mol Endocrinol; 1999 Mar; 13(3):466-75. PubMed ID: 10077003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
    Loeffler S; Fayard B; Weis J; Weissenberger J
    Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin-E2 enhances EPO-mediated STAT5 transcriptional activity by serine phosphorylation of CREB.
    Boer AK; Drayer AL; Rui H; Vellenga E
    Blood; 2002 Jul; 100(2):467-73. PubMed ID: 12091337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
    Calin-Jageman IE; Wang J; Bannon MJ
    J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
    Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
    Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
    Kanda N; Watanabe S
    J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
    Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling.
    Li TF; Zuscik MJ; Ionescu AM; Zhang X; Rosier RN; Schwarz EM; Drissi H; O'Keefe RJ
    Exp Cell Res; 2004 Oct; 300(1):159-69. PubMed ID: 15383323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.